About
About Circio
CEO Statement
Pipeline
Management Team
Board of Directors
Careers
The Norwegian Transparency Act
circRNA
Circio AB
circVec platform
Clinical programs
KRAS program
Publications
Partnering
Investors
Rights issue 2024
Press releases
Events
Reports
Presentations
Prospectus
Debt
Share facts
Largest shareholders
Dividend policy
Analyst coverage
Registrar and auditor
Corporate Governance Policy
Code of Conduct
Corporate Social Responsibility Principles
Remuneration Principles
About General Meeting
General Meetings
Articles of Association
Board of Directors
Nomination Committee
Committees
Management
Contact
Media
Press releases
Events
Subscribe
Contact
Contacts
About
About Circio
CEO Statement
Our pipeline
Management Team
Board of Directors
Careers
The Norwegian Transparency Act
circRNA
Circio AB
circVec platform
Clinical programs
KRAS program
Publications
Partnering
Partnering
Investors
Rights issue 2024
Press releases
Events
Reports
Presentations
Prospectus
Debt
Share information
Share and trading information
Largest shareholders
Dividend policy
Analyst coverage
Registrar and auditor
Corporate Governance Policy
Code of Conduct
Corporate Social Responsibility Principles
Remuneration Principles
About General Meeting
General Meetings
Articles of Association
Board of Directors
Nomination Committee
Committees
Management
Contact
Media
Press releases
Events
Subscribe
Contact
Contacts
Offices
Investors & Media
Search for:
Other
All press releases
Press releases - Regulatory
Press releases - Non-regulatory
2011
2022
2019
2018
2017
2016
2015
2014
2013
2012
All years
Other
All subjects
Corporate news
November 28, 2011
Press release - Non-regulatory
9 million NOK for development of cancer vaccine
June 13, 2011
Press release - Non-regulatory
Targovax AS received a grant from Innovation Norway
